Cody focuses his practice on health care transactions and advises health care organizations on regulatory, compliance, and governance matters. He regularly negotiates and drafts documents for mergers, acquisitions, and reorganizations. Cody assists clients with formation and dissolution, governance disclosures to state regulatory bodies, employment agreements, and licensure and certification applications. His practice involves preparing a wide variety of corporate and commercial agreements, including license and service agreements. In addition, Cody represents clients in the technology and life sciences industries.
Prior to joining Mintz, Cody was an associate at a Long Island, New York–based boutique law firm that serves the health care industry, where he handled transactional, corporate, and compliance matters.
While attending law school, Cody had a number of internships and externships focusing on legal issues affecting the health care sector, including with the Health Care Bureau of the New York State Attorney General’s Office and the Centers for Disease Control and Prevention in Atlanta, researching and drafting pleadings, motions, and memorandums on health law and other legal issues. Cody also worked as a legal extern at the American Cancer Society in Atlanta and a legal intern at the Children's Cancer & Blood Foundation in New York, where he focused on contracting and corporate governance matters.
Cody participated in the Transactional Law Certificate Program at Emory University School of Law.
- Emory University (JD)
- University of Michigan (BA)
New York Establishes First Pharmacy Benefits Bureau in the Nation as Registration and Annual Reporting Deadlines for Pharmacy Benefit Managers Approach
May 25, 2022 | Blog | By Tara E. Dwyer, Cody Keetch, Jean D. Krebs
February 28, 2022 | Article
February 25, 2022 | Blog | By Cody Keetch, Jean D. Krebs, Nick Torres
December 21, 2021 | Blog | By Cody Keetch, Jean D. Krebs
November 23, 2021 | Blog | By Cody Keetch, Jean D. Krebs
PhRMA Updates its Code on Interactions with Health Care Professionals in Response to the OIG's Special Fraud Alert on Speaker Programs
August 17, 2021 | Blog | By Rachel Yount, Cody Keetch, Joe Ort
The changes to the PhRMA Code are undoubtedly in response to a November 16, 2020, Special Fraud Alert from the Department of Health and Human Services’ Office of the Inspector General (OIG), on “fraud and abuse risks associated … speaker programs.” (For additional information on the OIG’s Special Fraud Alert, please see our November 25, 2020 blog post.) Speaker programs are a common practice in the industry and generally entail pharmaceutical and medical device companies retaining health care professionals (HCPs) to speak or present to educate their peers on the companies’ drugs or devices.